BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32809251)

  • 21. RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.
    Kato I; Furuya M; Baba M; Kameda Y; Yasuda M; Nishimoto K; Oyama M; Yamasaki T; Ogawa O; Niino H; Nakaigawa N; Yano Y; Sakamoto K; Urata Y; Mikami K; Yamasaki S; Tanaka R; Takagi T; Kondo T; Nagashima Y
    Histopathology; 2019 Aug; 75(2):254-265. PubMed ID: 30908700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.
    Argani P; Hicks J; De Marzo AM; Albadine R; Illei PB; Ladanyi M; Reuter VE; Netto GJ
    Am J Surg Pathol; 2010 Sep; 34(9):1295-303. PubMed ID: 20679884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma.
    Woo S; Kim SY; Lee MS; Moon KC; Kim SH; Cho JY; Kim SH
    AJR Am J Roentgenol; 2015 Mar; 204(3):542-9. PubMed ID: 25714283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.
    Hayes M; Peckova K; Martinek P; Hora M; Kalusova K; Straka L; Daum O; Kokoskova B; Rotterova P; PivovarĨikova K; Branzovsky J; Dubova M; Vesela P; Michal M; Hes O
    Virchows Arch; 2015 Mar; 466(3):313-22. PubMed ID: 25544614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.
    Komai Y; Fujiwara M; Fujii Y; Mukai H; Yonese J; Kawakami S; Yamamoto S; Migita T; Ishikawa Y; Kurata M; Nakamura T; Fukui I
    Clin Cancer Res; 2009 Feb; 15(4):1170-6. PubMed ID: 19228722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
    Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
    Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imprint cytologic features in renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in an adult: a case report.
    Yamaguchi T; Kuroda N; Imamura Y; Hes O; Kawada T; Nakayama K
    Acta Cytol; 2009; 53(6):693-7. PubMed ID: 20014561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital.
    Hung CC; Pan CC; Lin CC; Lin AT; Chen KK; Chang YH
    J Chin Med Assoc; 2011 Nov; 74(11):500-4. PubMed ID: 22100019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma.
    Zhu QQ; Wang ZQ; Zhu WR; Chen WX; Wu JT
    Acta Radiol; 2013 Apr; 54(3):355-62. PubMed ID: 23446748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect.
    Kuroda N; Mikami S; Pan CC; Cohen RJ; Hes O; Michal M; Nagashima Y; Tanaka Y; Inoue K; Shuin T; Lee GH
    Histol Histopathol; 2012 Feb; 27(2):133-40. PubMed ID: 22207547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features of Xp11.2 translocation renal cell carcinoma.
    Lim B; You D; Jeong IG; Kwon T; Hong S; Song C; Cho YM; Hong B; Hong JH; Ahn H; Kim CS
    Korean J Urol; 2015 Mar; 56(3):212-7. PubMed ID: 25763125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine-needle aspiration of a Xp11.2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung: report of a case and review of the literature.
    Schinstine M; Filie AC; Torres-Cabala C; Abati A; Linehan WM; Merino M
    Diagn Cytopathol; 2006 Nov; 34(11):751-6. PubMed ID: 17121198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of TFE3 translocation renal cell carcinoma with rare morphological features and literature review.
    Xia T; Long H; Liao D; Wang W; Xiao X
    Indian J Pathol Microbiol; 2023; 66(1):135-140. PubMed ID: 36656224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population.
    Qu Y; Gu C; Wang H; Chang K; Yang X; Zhou X; Dai B; Zhu Y; Shi G; Zhang H; Ye D
    Sci Rep; 2016 Feb; 6():21677. PubMed ID: 26880493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rare case of TFE-related pigmented renal tumor with overlapping features between melanotic Xp11 translocation renal cancer and Xp11 renal cell carcinoma with melanotic features.
    Cardili L; Wrublevsky Pereira G; Viana CR
    Pathol Int; 2017 Apr; 67(4):208-213. PubMed ID: 28208226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and Classification.
    Wang XT; Xia QY; Zhou XJ; Rao Q
    Crit Rev Oncog; 2017; 22(5-6):481-497. PubMed ID: 29604926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic Features of Translocation Renal Cell Carcinoma.
    Ellati RT; Abukhiran I; Alqasem K; Jasser J; Khzouz J; Bisharat T; Al-Saidi I; Al-Daghmin A
    Clin Genitourin Cancer; 2017 Feb; 15(1):112-116. PubMed ID: 27372562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement.
    Zhong M; Weisman P; Zhu B; Brassesco M; Yang Y; Linehan WM; Merino MJ; Zhang D; Rohan S; Cai D; Yang X
    Diagn Mol Pathol; 2013 Jun; 22(2):107-11. PubMed ID: 23628822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of immunohistochemistry, FISH and RT-PCR shows high incidence of Xp11 translocation RCC: comparison of three different diagnostic methods.
    Lee HJ; Shin DH; Noh GY; Kim YK; Kim A; Shin N; Lee JH; Choi KU; Kim JY; Lee CH; Sol MY; Rha SH; Park SW
    Oncotarget; 2017 May; 8(19):30756-30765. PubMed ID: 28415646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network.
    Malouf GG; Camparo P; Oudard S; Schleiermacher G; Theodore C; Rustine A; Dutcher J; Billemont B; Rixe O; Bompas E; Guillot A; Boccon-Gibod L; Couturier J; MoliniƩ V; Escudier B
    Ann Oncol; 2010 Sep; 21(9):1834-1838. PubMed ID: 20154303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.